Genmab A/S provided an update on its share buy-back program, reporting transactions executed from April 28 to May 2, 2025. The program was initiated on March 25, 2025, with the aim of repurchasing up to 2.2 million shares.
Following these transactions, Genmab now holds 1,942,500 shares as treasury shares. This amount corresponds to 3.03% of the company's total share capital and voting rights.
The share buy-back program is expected to be completed no later than July 10, 2025. It is undertaken in accordance with the Safe Harbour Regulation, aiming to reduce capital and honor commitments under the Restricted Stock Unit program.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.